Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

KISQALI 200 MG

RIBOCICLIB (RIBOCICLIB SUCCINATE) 200 MG · DIN 02473569 · NOVARTIS PHARMACEUTICALS CANADA INC

Health Canada status: MARKETED

KISQALI 200 MG Tablet - DIN 02473569
KISQALI — DIN 02473569. Product photograph held by Nexara Health.

What is KISQALI?

KISQALI 200 MG contains RIBOCICLIB (RIBOCICLIB SUCCINATE) 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02473569, held by NOVARTIS PHARMACEUTICALS CANADA INC, supplied as Tablet for Oral administration. Health Canada currently lists it as marketed, status dated 27-Apr-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02473569
Brand nameKISQALI
Generic / active ingredientRIBOCICLIB (RIBOCICLIB SUCCINATE) 200 MG
ManufacturerNOVARTIS PHARMACEUTICALS CANADA INC
Strength200 MG
Dosage formTablet
Route of administrationOral
SchedulePrescription
ATC codeL01EF02 RIBOCICLIB
AHFS class10:00.00
BiosimilarNo
Health Canada statusMARKETED
Status date27-Apr-2018
Original market date2018-04-27 00:00:00

Who else supplies RIBOCICLIB worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. RIBOCICLIB appears in 43 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for KISQALI

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for KISQALI

Health Canada Drug Product Database (DPD), DIN 02473569. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.